Rua commences legal proceedings against Cann Group

FOR PUBLIC RELEASE
NZX Limited
Wellington
15
th
February 2024

Rua Bioscience commences legal proceedings against Cann Group
Tairawhiti, New Zealand – Rua Bioscience has today served legal proceedings against Cannoperations
Pty Ltd (Cann), a wholly owned subsidiary of Cann Group Limited in Australia, claiming damages for a
breach of contractual rights to exclusively sell Cann’s medicinal cannabis products in Australia.
On 4 December 2023, Rua Bioscience announced that Cann Group had given 12 months’ notice to
terminate its existing supply contract, which is between Cann and Rua.
The proceedings commenced by Rua in the Supreme Court of Victoria today are in respect of a claim
by Rua that Cann has breached an exclusive supply term provided for in the supply contract. That
exclusive supply term provides that Cann will supply specific medicinal cannabis products exclusively
to Rua for re-sale in Australia and New Zealand during the term of the contract. Rua is of the view that
these breaches have caused Rua to suffer significant damages.
ENDS
The person who authorised this announcement:

Paul Naske
Chief Executive Officer
Paul.naske@ruabio.com
+64 21 445154


For shareholder enquiries please visit www.ruabio.com or contact:
info@ruabio.com
0800 RUABIO


MATERIAL ANNOUNCEMENT